MEHMET TEOMETE

M.D. Mehmet Teomete is a medical oncologist with a medical degree from Marmara University Faculty of Medicine (2009). He has served at Acibadem Health Group since 2004, bringing years of clinical experience in cancer care and patient management. M.D. Teomete is an active member of the Medical Oncology Society and the Turkish Medical Association, maintaining engagement with professional standards and continuing education. He is committed to evidence-based treatment, compassionate patient communication, and collaborative care with multidisciplinary teams.

Education

• 2009 Marmara University Faculty of Medicine Medical Oncology
• 2003 Haydarpasa Numune Training and Research Hospital Internal Medicine
• 1994 Ankara University Faculty of Medicine

Experience

• 2010 Trabzon Numune Training and Research Hospital / Medical Oncology Specialist
• 2009 – 2010 Erzurum Regional Training and Research Hospital / Medical Oncology Specialist
• 2005 – 2009 Marmara University Faculty of Medicine / Subspecialty Training
• 2003 – 2005 Haydarpasa Numune Training and Research Hospital / Internal Medicine Specialist
• 2004 Acibadem Health Group
• 1998 – 2003 Haydarpasa Numune Training and Research Hospital / Internal Medicine Assistant
• 1996 – 1998 Trabzon Merkez Çağlayan Health Center / General Practitioner
• 1994 – 1996 Trabzon Düzköy District Aykut Town Health Center / General Practitioner

Memberships

• Medical Oncology Society
• Turkish Medical Association

Publications

• Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature
  J Oncol Pharm Pract September 21, 20101078155210384755 Timur Koca Zuleyha Akgun zuleyh@hotmail.com Serap Baskaya Yucel Nihal Zerman Dag Mehmet Teomete
• Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey
  Medical Oncology 001: 10.1007js12032-010-9463-x Gul Basaran, Nazlm Serdar Turhal, Devrim Cabukr Nevin Yurt, Gul Yurtseven, Mahmut Gumus, Mehmet Teomete, Faysal Dane and Perran Fulden Yumuk
• 0utcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete and N. S. Turhal
  18S (June 20 Supplement), 2007: 14588© 2007 American Society of Clinical Oncology Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No
• Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC) P. F. Yumuk, M. Teomete, F. Dane, D. Cabuk, G. Basaran and N. S. Turhal Marmara University Medical School Hospital, Istanbul, Turkey
  15S (May 20 Supplement), 2009: e19055© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No
• Pulmonary toxicity in patients receiving docetaxel chemotherapy U. Kefeli, P. F. Yumuk, B. Ceyhan, F. Dane, B. Eroglu, D. Cabuk, G. Basaran, M. Teomete and N. S. Turhal.
  No 15S (May 20 Supplement), 2009: e13532© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27,
• Benefit from adjuvant anthracyclines according to hormone receptor status G. Atalay Basaran, D. Cabuk, M. Teomete, B. Gulluoglu, H. Kaya, F. Dane, P. F. Yumuk and N. S. Turhal
  Vol 26, No 15S (May 20 Supplement), 2008: 11513© 2008 American Society of Clinical Oncology Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
• The relationship between glycemic control and platelet activity in type 2 diabetes mellitus
  Received May 24, 2007; received in revised form January 7, 2008; accepted January 18, 2008. published online March 25, 2008. Refik Demirtunc, Dursun Duman, Melih Basar, Mustafa Bilgi, Mehmet Teomete, Tayfun Garip
• A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin’s lymphoma: the importance of second opinion.
  J aVON. 2009 Apr-Jun;14(2):309-11 Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, Turhal NS.
• Clinical outcome of triple-negative (TN) breast cancer (BC) D. Cabuk, G. Basaran, H. Kaya, B. Gulluoglu, M. Teomete, F. Dane, P. F. Yumuk and N. S. Turhal
  (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: 11526 © 2008 American Society of Clinical Oncology MUTFH, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings
• Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience F. Dane, M. Gumus, M. A. Ozturk, D. Cabuk, M. B. Atasoy, P. F. Yumuk, G. Basaran, M. S. Iyikesici, M. Teomete, U. Abacioglu and N. S. Turhal
  Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Marmara University Medical Oncology, Istanbul, Turkey; Marmara University Radiation Oncology, Istanbul, Turkey
• Clinical outcome of node-negative (NN) breast cancer (BC) patients
  Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). G. Atalay Basaran, D. Cabuk, F. Dane, M. Teomete, S. Iyikesici, E. Meltem, B. Gulluoglu, H. Kaya, U. AbaCloglu, F. Yumuk and S. Turhal
• 0utcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey
  Journal of Thoracic Oncology: August 2007 – Volume 2 – Issue 8 – p S701 doi: 10.1 097jOl.JTO. 0000284031.87598.62 Yumuk, Perran F.; Teomete, Mehmet; Dane, Faysal; Cabuk, Devrim; Caglar, Hale B.; Abacioglu, Ufuk; Basaran, Gul; Turhal, Nazim S.